Articles on Drug-resistant TB
Displaying all articles
The overcrowded conditions of prisons make them a high-risk environment for the spread of infectious diseases such as TB.
Many of the most fundamental aspects of TB disease remain unknown. For example, after exposure to the organism that causes TB, why do only some people get infected and only some of those fall ill?
There’s a big market for new treatments for TB, malaria and other ailments. But most of these diseases afflict low-income people unable to pay for medicine.
New research shows that the treatment of drug resistant-TB can be reduced from the current duration of 20 to 24 months to less than a year.
Using a large number of computers to screen TB drugs reduces the cost and time.
Treatment for drug-resistant TB remains problematic as the painful daily injectable patients receive for at least six months leaves more than 60% deaf.
The health care debate in the US has focused on a looming crisis, with millions possibly losing insurance coverage. In India, an immediate crisis looms with tuberculosis.
To tackle TB a dynamic change in discourse is needed. The focus must be on how to respond to emerging complexities the disease presents.







